Dmitry Balyasny’s 89bio ETNB Stock Holding History

Dmitry Balyasny’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,459,055	Closed	-$21.4M	–	3220
2025 Q3	$21.4M	Buy	+1,459,055	New	+$14.9M	0.03%	688
2025 Q2	–	Sell	-336,649	Closed	-$2.45M	–	2972
2025 Q1	$2.45M	Sell	336,649 -682,800	-67%	-$5.97M	﹤0.01%	1612
2024 Q4	$7.97M	Buy	+1,019,449	New	+$8.39M	0.01%	1062
2024 Q3	–	Sell	-40,656	Closed	-$326K	–	2852
2024 Q2	$326K	Buy	40,656 +15,334	+61%	+$137K	﹤0.01%	2208
2024 Q1	$295K	Buy	+25,322	New	+$280K	﹤0.01%	2268
2023 Q1	–	Sell	-22,159	Closed	-$282K	–	2799
2022 Q4	$282K	Buy	+22,159	New	+$199K	﹤0.01%	2015

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Dmitry Balyasny's ETNB Position: Q4 2025 in Review

Dmitry Balyasny sold out of 89bio (ETNB) in Q4 2025, closing a stake of 1,459,055 shares — an estimated $21.4M sold.

Dmitry Balyasny first reported a position in ETNB in Q4 2022 and held it in 6 quarters. The position peaked at $21.4M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Dmitry Balyasny reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Dmitry Balyasny sold 1,459,055 89bio shares in Q4 2025, an estimated $21.4M.
Dmitry Balyasny first reported a position in 89bio in Q4 2022 and held it in 6 quarters.
Dmitry Balyasny's 89bio position peaked at $21.4M in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.